Your account is not claimed yet. You can sign up with ORCID to claim your account.

Emanuele Zucca (E Zucca)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 35

Top Venues

Hematological oncology

Blood

Journal of clinical medicine

Blood advances

IOR Insitute of Oncology Research

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IOR Insitute of Oncology Research

Switzerland

Group Leader :: International Extranodal Lymphoma Study Group

Publications

Francesca Guidetti, Alberto J Arribas, Giulio Sartori, Filippo Spriano, Laura Barnabei, Chiara Tarantelli, Reinhard Von Roemeling, Elizabeth Martinez, Emanuele Zucca, Francesco Bertoni
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of clinical medicine 12 (2) (2023)
Francesca Guidetti, Alberto J Arribas, Giulio Sartori, Filippo Spriano, Laura Barnabei, Chiara Tarantelli, Reinhard Von Roemeling, Elizabeth Martinez, Emanuele Zucca, Francesco Bertoni
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of clinical medicine 12 (2) (2023)
Francesca Guidetti, Alberto J Arribas, Giulio Sartori, Filippo Spriano, Laura Barnabei, Chiara Tarantelli, Reinhard Von Roemeling, Elizabeth Martinez, Emanuele Zucca, Francesco Bertoni
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of clinical medicine 12 (2) (2023)
Côme Bommier, Emanuele Zucca, Sylvie Chevret, Annarita Conconi, Grzegorz S Nowakowski, Matthew J Maurer, James R Cerhan, Catherine Thieblemont, Jerome Lambert
Early Complete Response as Validated Surrogate Marker in Extranodal Marginal Zone Lymphoma Systemic Therapy. Blood (2023)
Francesca Guidetti, Alberto J Arribas, Giulio Sartori, Filippo Spriano, Laura Barnabei, Chiara Tarantelli, Reinhard Von Roemeling, Elizabeth Martinez, Emanuele Zucca, Francesco Bertoni
Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. Journal of clinical medicine 12 (2) (2023)
Alberto J Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua Adjeiwaa Mensah, Filippo Spriano, Antonella Zucchetto, Francesca Maria Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stussi, Valter Gattei, Jennifer R Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms. Molecular cancer therapeutics (2023)
Jakoba Johanna Eertink, Gerben J C Zwezerijnen, Martijn Heymans, Simone Pieplenbosch, Sanne Elisabeth Wiegers, Ulrich Dührsen, Andreas Huettmann, Lars Kurch, Christine Hanoun, Pieternella J Lugtenburg, Sally F Barrington, N George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sandor Czibor, Tamás Györke, Martine E D Chamuleau, Otto S Hoekstra, Henrica C W de Vet, Ronald Boellaard, Josée J M Zijlstra-Baalbergen
Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma. Blood (2023)
Alberto J Arribas, Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas, Eugenio Gaudio, Chiara Tarantelli, Afua Adjeiwaa Mensah, Filippo Spriano, Antonella Zucchetto, Francesca Maria Rossi, Andrea Rinaldi, Manuel Castro de Moura, Sandra Jovic, Roberta Bordone Pittau, Anastasios Stathis, Georg Stussi, Valter Gattei, Jennifer R Brown, Manel Esteller, Emanuele Zucca, Davide Rossi, Francesco Bertoni
ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms. bioRxiv : the preprint server for biology (2023)
Alberto J Arribas, Eugenio Gaudio, Sara Napoli, Charles Jean Yvon Herbaux, Chiara Tarantelli, Roberta Pittau Bordone, Luciano Cascione, Nicolas Munz, Luca Aresu, Jacopo Sgrignani, Andrea Rinaldi, Ivo Kwee, Davide Rossi, Andrea Cavalli, Emanuele Zucca, Georg Stussi, Anastasios Stathis, Callum Sloss, Matthew S Davids, Francesco Bertoni
PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine. bioRxiv : the preprint server for biology (2023)
Andrés José Maria Ferreri, Kate Cwynarski, Elisa Pulczynski, Christopher P Fox, Elisabeth Schorb, Claudia Celico, Monica Falautano, Alessandro Nonis, Paul La Rosée, Mascia Binder, Alberto Fabbri, Fiorella Ilariucci, Mauro Krampera, Alexander Roth, Claire Hemmaway, Peter W Johnson, Kim M Linton, Tobias Pukrop, Jettes Sønderskov Gørløv, Monica Balzarotti, Georg Hess, Ulrich Bernd Keller, Stephan Stilgenbauer, Jens Peter Panse, Alessandra Tucci, Lorella Orsucci, Francesco Pisani, Manuela Zanni, Stefan W Krause, Hans J Schmoll, Bernd Hertenstein, Mathias Rummel, Jeffery Smith, Lorenz Thurner, Giuseppina Cabras, Elsa Pennese, Maurilio Ponzoni, Martina Deckert, Letterio S Politi, Juergen Finke, Antonella Ferranti, Kelly Cozens, Elvira Burger, Nicoletta Ielmini, Franco Cavalli, Emanuele Zucca, Gerald Illerhaus, null null
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial. Leukemia 36 (7) (2022)
Laurence de Leval, Ash A Alizadeh, Peter Leif Bergsagel, Elias Campo, Andrew John Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William George Morice, Ryan D Morin, Bertrand Nadel, Stefano A Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverria, Christian Steidl, Steven P Treon, Andrew D Zelenetz, Ranjana H Advani, Carl E Allen, Stephen M Ansell, Wing C John Chan, James R Cook, Lucy B M Cook, Francesco d'Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G Gribben, Olivier Hermine, Daniel James Hodson, Eric D Hsi, Giorgio Ga Inghirami, Elaine S Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfram Klapper, Won Seog Kim, Rebecca L King, Young-Hyeh Ko, Ann Steward LaCasce, Georg Lenz, José I Martin-Subero, Miguel Angel Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla-Martínez, Scott J Rodig, Andreas Rosenwald, Gilles Andre Salles, Jesús San F Miguel, Kerry J Savage, Laurie Helen Sehn, Gianpietro C Semenzato, Louis M Staudt, Steven Howard Swerdlow, Constantine S Tam, Judith Trotman, Julie M Vose, Oliver Weigert, Wyndham H Wilson, Jane N Winter, Catherine J Wu, Pier Luigi Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W Scott
Genomic profiling for clinical decision making in lymphoid neoplasms. Blood 140 (21) (2022)
Gabriela Forestieri, Lodovico Terzi di Bergamo, Marina Deodato, Anna Maria Frustaci, Riccardo Moia, Clara Deambrogi, Silvia Rasi, Francesco Autore, Michele Merli, Roberta Mattarucchi, Gaby Fahrni, Lydia Scarfo', Daniela Gussetti, Pietro Bulian, Annagiulia Zanatta, Valeria Spina, Alessio Bruscaggin, Katia Pini, Deborah Piffaretti, Maria Cristina Pirosa, Matin Salehi, Joyce Marques de Almeida, Jakob Passweg, Franco Cavalli, Emanuele Zucca, Bernhard Gerber, Georg Stussi, Valter Gattei, Paolo Ghia, Michael Gregor, Francesco Passamonti, Luca Laurenti, Gianluca Gaidano, Alessandra Tedeschi, Davide Rossi, Adalgisa Condoluci
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia. Hematological oncology (2022)
Côme Bommier, Jérôme Lambert, Grzegorz Nowakowski, Emanuele Zucca, Catherine Thieblemont
Finding a consensus on time-to-event endpoints definitions in marginal zone lymphoma: A Delphi method. Hematological oncology (2022)
Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martínez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Dogan, Andrew L Feldman, Falko Fend, Jonathan W Friedberg, Philippe Gaulard, Paolo Ghia, Steven M Horwitz, Rebecca L King, Gilles Andre Salles, Jesús San F Miguel, John Francis Seymour, Steven P Treon, Julie M Vose, Emanuele Zucca, Ranjana Advani, Stephen Ansell, Wing-Yan Au, Carlos Barrionuevo, Peter Leif Bergsagel, Wing C Chan, Jeffrey I Cohen, Francesco d'Amore, Andrew John Davies, Brunangelo Falini, Irene M Ghobrial, Mariusz A Wasik, John G Gribben, Eric D Hsi, Brad S Kahl, Won-Seog Kim, Shaji K Kumar, Ann Steward LaCasce, Camille Laurent, Georg Lenz, John P Leonard, Michael P Link, Armando Lopez-Guillermo, Maria-Victoria Mateos-Manteca, Elizabeth A Macintyre, Ari M Melnick, Judith Trotman, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano A Pileri, Miguel Angel Piris, Barbara Pro, Vincent Rajkumar, Steven T Rosen, Birgitta Sander, Laurie Sehn, Margaret A Shipp, Sonali M Smith, Louis M Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H Wilson, Tadashi Yoshino, Pier Luigi Luigi Zinzani, Martin Dreyling, David W Scott, Jane N Winter, Andrew D Zelenetz
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood 140 (11) (2022)
Sofia Genta, Guido Ghilardi, Luciano Cascione, Darius Juskevicius, Alexandar Tzankov, Sämi Schär, Lisa Milan, Maria Cristina Pirosa, Fabiana Esposito, Teresa Ruberto, Luca M Giovanella, Stefanie Hayoz, Christoph Mamot, Stefan Dirnhofer, Emanuele Zucca, Luca Ceriani
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. Cancers 14 (4) (2022)
Luca Ceriani, Emanuele Zucca
D max : A simple and reliable PET/CT-derived new biomarker of lymphoma outcome? Hematological oncology (2022)
Davide Rossi, Francesco Bertoni, Emanuele Zucca
Marginal-Zone Lymphomas. The New England journal of medicine 386 (6) (2022)
Luca Ceriani, Lisa Milan, Luciano Cascione, Giuseppe Gritti, Federico Dalmasso, Fabiana Esposito, Maria Cristina Pirosa, Sämi Schär, Andrea Bruno, Stephan Dirnhofer, Luca Giovanella, Stefanie Hayoz, Christoph Mamot, Alessandro Rambaldi, Stephane Chauvie, Emanuele Zucca
Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis. Hematological oncology (2021)
Chiara Tarantelli, Eleonora Cannas, Hillarie Ekeh, Carmelo Moscatello, Eugenio Gaudio, Luciano Cascione, Sara Napoli, Cesare Rech, Andrea Testa, Chiara Maniaci, Andrea Rinaldi, Emanuele Zucca, Anastasios Stathis, Alessio Ciulli, Francesco Bertoni
The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type. Exploration of targeted anti-tumor therapy 2 (6) (2021)
Afua Adjeiwaa Mensah, Filippo Spriano, Giulio Sartori, Valdemar Priebe, Luciano Cascione, Eugenio Gaudio, Chiara Tarantelli, Elisa Civanelli, Luca Aresu, Andrea Rinaldi, Giovanna Damia, Emanuela Lovati, Emanuele Zucca, Anastasios Stathis, Claudio Pietra, Francesco Bertoni
Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors. Blood advances 5 (10) (2021)
Jakoba Johanna Eertink, C N Burggraaff, M W Heymans, U Dührsen, Andreas Huettmann, C Schmitz, S Müller, Pieternella J Lugtenburg, Sally F Barrington, N George Mikhaeel, R Carr, S Czibor, Tamás Györke, Luca Ceriani, Emanuele Zucca, Martin Hutchings, L Kostakoglu, A Loft, S Fanti, Sanne Elisabeth Wiegers, S Pieplenbosch, R Boellaard, O S Hoekstra, Josée J M Zijlstra-Baalbergen, Henrica C W de Vet
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients. Blood advances 5 (9) (2021)
Alessio Bruscaggin, Lodovico Terzi di Bergamo, Valeria Spina, Brendan Hodkinson, Gabriela Forestieri, Ferdinando Bonfiglio, Adalgisa Condoluci, Wei Wu, Maria C Pirosa, Martin Richard Faderl, Ricardo Koch, Michael Schaffer, John D Alvarez, Nele Fourneau, Bernhard Gerber, Georg Stussi, Emanuele Zucca, Sriram Balasubramanian, Davide Rossi
Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab. Blood advances 5 (22) (2021)
Ferdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, Lodovico Terzi di Bergamo, Martin Richard Faderl, Valeria Spina, Adalgisa Condoluci, Luisella Bonomini, Gabriela Forestieri, Ricardo Koch, Deborah Piffaretti, Katia Pini, Maria C Pirosa, Micol Giulia Cittone, Alberto J Arribas, Marco Lucioni, Guido Ghilardi, Wei Wu, Luca Arcaini, Maria Joao Baptista, Gabriela Bastidas, Sílvia Beà, Renzo Boldorini, Alessandro Broccoli, Marco Matteo Bühler, Vincenzo Canzonieri, Luciano Cascione, Luca Ceriani, Sergio B Cogliatti, Paolo Corradini, Enrico Derenzini, Liliana Devizzi, Sascha Dietrich, Angela Rita Elia, Fabio Facchetti, Gianluca Gaidano, Juan Fernando García, Bernhard Gerber, Paolo Ghia, Maria Gomes da Silva, Giuseppe Gritti, Anna Guidetti, Felicitas Hitz, Giorgio Ga Inghirami, Marco Ladetto, Armando López-Guillermo, Elisa Lucchini, Antonino Maiorana, Roberto Marasca, Estella Matutes, Véronique Meignin, Michele Merli, Alden A Moccia, Manuela Mollejo, Carlos Montalban, Urban Novak, David Graham Oscier, Francesco Passamonti, Francesco A Piazza, Stefano Pizzolitto, Alessandro Rambaldi, Elena Sabattini, Gilles Andre Salles, Elisa Santambrogio, Lydia Scarfo, Anastasios Stathis, Georg Stussi, Julia Turbiner Geyer, Gustavo Tapia, Corrado Tarella, Catherine Thieblemont, Thomas Tousseyn, Alessandra Tucci, Giorgio Vanini, Carlo Visco, Umberto Vitolo, Renata Walewska, Francesco Zaja, Thorsten Zenz, Pier Luigi Luigi Zinzani, Hossein Khiabanian, Arianna Calcinotto, Francesco Bertoni, Govind Bhagat, Elias Campo, Laurence de Leval, Stefan Dirnhofer, Stefano A Pileri, Miguel A Piris, Alexandra Traverse-Glehen, Alexandar Tzankov, Marco Paulli, Maurilio Ponzoni, Luca Mazzucchelli, Franco Cavalli, Emanuele Zucca, Davide Rossi
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood (2021)
Emanuele Zucca, Luciano Cascione, Teresa Ruberto, Davide Facchinelli, Sämi Schär, Stefanie Hayoz, Stefan Dirnhofer, Luca M Giovanella, Mario Bargetzi, Christoph Mamot, Luca Ceriani
Prognostic models integrating quantitative parameters from baseline and interim positron emission computed tomography in patients with diffuse large B-cell lymphoma: post-hoc analysis from the SAKK38/07 clinical trial. Hematological oncology 38 (5) (2020)
Barbara Vannata, Anna Vanazzi, Mara Negri, Sarah Jayne Liptrott, Anna Amalia Bartosek, Monica Miani, Alessandro Di Sanzo, Franco Cavalli, Emanuele Zucca, Anastasios Stathis
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomas. Hematological oncology 39 (1) (2020)
Alden Alberto Moccia, Stefanie Aeppli, S Güsewell, M Bargetzi, C Caspar, D Brülisauer, M Ebnöther, M Fehr, N Fischer, G Ghilardi, F Krasniqi, N Lang, U Mey, W Mingrone, U Novak, C Pfleger, P Richter, M Rütti, A Schmidt, F Stenner, M Voegeli, T Zander, Emanuele Zucca, F Hitz
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland. Hematological oncology 39 (2) (2020)
Emanuele Zucca, Stephanie Rondeau, Anna Vanazzi, Bjørn Østenstad, Ulrich J M Mey, Daniel Rauch, Björn E Wahlin, Felicitas Hitz, Micaela Hernberg, Ann-Sofie Johansson, Peter de Nully Brown, Hans Hagberg, Andrés José Maria Ferreri, Andreas Lohri, Urban Novak, Thilo Zander, Hanne Bersvendsen, Mario Bargetzi, Walter Mingrone, Fatime Krasniqi, Stefan Dirnhofer, Stefanie Hayoz, Hanne Hawle, Simona Berardi Vilei, Michele Ghielmini, Eva Kimby, null null
Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy. Blood 134 (4) (2019)
Andreas M Schmitt, Amanda K Herbrand, Christopher P Fox, Katerina Bakunina, Jacoline E C Bromberg, Kate Cwynarski, Jeanette K Doorduijn, Andrés J M Ferreri, Gerald Illerhaus, Samar Issa, Elisabeth Schorb, Emanuele Zucca, Lars G Hemkens, Stefan Schandelmaier, Benjamin Kasenda
Rituximab in primary central nervous system lymphoma-A systematic review and meta-analysis. Hematological oncology 37 (5) (2019)
Francesco Bertoni, Davide Rossi, Emanuele Zucca
Recent advances in understanding the biology of marginal zone lymphoma. F1000Research 7 (2018)
Annarita Conconi, Emanuele Zucca, Gloria Margiotta-Casaluci, Katharine Darling, Barbara Hasse, Manuel Battegay, Cornelia Staehelin, Urban Novak, Patrick Schmid, Alexandra Scherrer, Stephan Dirnhofer, Ivo Kwee, Luca Nassi, Franco Cavalli, Gianluca Gaidano, Francesco Bertoni, Enos Bernasconi, null null
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. Hematological oncology 36 (5) (2018)
Luca Ceriani, Lisa Milan, Maurizio Martelli, Andrés J M Ferreri, Luciano Cascione, Pier Luigi Zinzani, Alice Di Rocco, Annarita Conconi, Anastasios Stathis, Franco Cavalli, Monica Bellei, Kelly Cozens, Elena Porro, Luca M Giovanella, Peter W Johnson, Emanuele Zucca
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma. Blood 132 (2) (2018)
Carla Minoia, Emanuele Zucca, Annarita Conconi
Novel acquisitions on biology and management of transformed follicular lymphoma. Hematological oncology 36 (4) (2018)
Anastasios Stathis, Alexia Iasonos, John F Seymour, Catherine Thieblemont, Vincent Ribrag, Emanuele Zucca, Anas Younes
Report of the 14th International Conference on Malignant Lymphoma (ICML) Closed Workshop on Future Design of Clinical Trials in Lymphomas. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (13) (2018)
Luca Ceriani, Maurizio Martelli, Annarita Conconi, Pier L Zinzani, Andrés J M Ferreri, Barbara Botto, Caterina Stelitano, Manuel Gotti, Maria G Cabras, Luigi Rigacci, Luca Giovanella, Emanuele Zucca, Peter W M Johnson
Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study. British journal of haematology 178 (4) (2017)
Randy D Gascoyne, Bertrand Nadel, Laura Pasqualucci, Jude Fitzgibbon, Jacqueline E Payton, Ari Melnick, Oliver Weigert, Karin Tarte, John G Gribben, Jonathan W Friedberg, John F Seymour, Franco Cavalli, Emanuele Zucca
Follicular lymphoma: State-of-the-art ICML workshop in Lugano 2015. Hematological oncology 35 (4) (2017)

Emanuele Zucca.css-eqlu8i{font-size:small;padding-left:4px;} (E Zucca)

Publication Activity (10 Years)

Top Topics

Top Venues

Emanuele Zucca (E Zucca)